AsthmaNCT07609134
The Development of the Walsh Asthma Self-management Programme and Feasibility of Implementation in Adults With Asthma in Primary Care
A study testing WASP asthma self-management programme in people with Asthma and Self-management, run by Royal College of Surgeons, Ireland at 1 site in Ireland.
Trial summary
Asthma is a common medical condition in Ireland. Adult patients tend to have periods when their asthma is stable and periods when it worsens. In order to reduce these periods of worsening asthma, effective ongoing management is required day to day by adults with asthma. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Asthma, Self-management, Asthma Control
- What is being tested?
- WASP asthma self-management programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 40 participants
- Where
- 1 siteIreland
- Study dates
- May 2026to Jan 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Adults over 18 years old
- Adults who meet one of the following criteria:
- a physician's diagnosis of asthma; coded as asthma (R96) as per the international classification of primary care (ICPC) or international classification of diseases (ICD) code J45 with associated use of asthma medications for 6 months prior to study enrolment.
Who cannot join
- Adults under 18 years old
- Adults with no diagnosis of asthma
- Adults receiving asthma education in a specialist hospital or community setting
- Adults unable to give informed consent
- Smoking ≥ 10 Pack Year History
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Ireland1 site, 1 recruiting
- Recruiting
Royal College of Surgeons Ireland
Dublin, D, D15 AXV5
Joanne Walsh, MSc, 01-4022300, joannewalsh21@rcsi.com
About this study
Asthma is a common medical condition in Ireland. Adult patients tend to have periods when their asthma is stable and periods when it worsens. In order to reduce these periods of worsening asthma, effective ongoing management is required day to day by adults with asthma. Teaching adults how to manage their asthma effectively, plays a huge role in improving their asthma and having a better overall quality of life. This education on managing asthma has many different parts to it. Most adults will discover they have asthma through their general practitioner (GP) and it will be continued to be checked and managed through their GP or general practice nurse (GPN) in their primary care clinic for the duration of their lives.
This research study is taking place to find out if a new education programme, will help adults manage their asthma better and improve the symptoms of asthma, reducing its overall impact on day-to-day life. This study is also looking at how easy it is to introduce and for nurses to deliver this study within a GP/ primary care centre. This study is to find out if this education programme works in a real life setting and if it can lead to better control of asthma for adults.
- Conditions
- Asthma, Self-management, Asthma Control
- Being tested
- WASP asthma self-management programme
- Keywords
- Asthma, self-management education, asthma control, primary care, nursing
- Medical subject headings
- Asthma
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
WASP asthma self-management programmeOther
all participants will received the WASP intervention which includes (asthma education, self-management training and behaviour change strategies)
| Study group | Role | What they receive |
|---|---|---|
| WASP intervetion | Experimental | Not described Receives: Other: WASP asthma self-management programme |
What is being measured
The primary outcome is the main question the study is designed to answer.
Feasibility of implementation
In terms of: recruitment, retention, response rates and service users' views of the intervention
Measured: 6 months
Education
Establish the nurses' frequency of education implementation
Measured: 6 months
Secondary outcomes (6)
Asthma Control Test Questionnaire
To determine level of asthma control
Measured: 6 months
Modified asthma self-efficacy questionnaire
To determine level of asthma self-efficacy
Measured: 6 months
Mini Asthma Quality of Life Questionnaire (mAQLQ)
To determine level of asthma associated quality of life
Measured: 6 months
Spirometry - Forced expiratory volume in 1 second (FEV1)
To monitor lung function - using FEV1
Measured: 6 months
Spirometry - Forced Vital Capacity (FVC)
To monitor lung function using FVC measurement
Measured: 6 months
Spirometry - Peak expiratory flow (PEF)
To monitor lung function using PEF measurements
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 May 2026
- Study startMay 2026 (estimated)
- Primary completionJan 2027 (estimated)
- Study completionJan 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for AsthmaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 40 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Royal College of Surgeons, Ireland
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07609134
- Sponsor's protocol ID
- REC202602014
- Status last verified
- May 2026
- First submitted
- 7 May 2026
- Last updated
- 27 May 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided: The data that support the findings of this study will be available from the corresponding author upon reasonable request
Study at a glance
From the registry record, last updated by the sponsor on 27 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Development of the Walsh Asthma Self-management Programme and Feasibility of Implementation in Adults With Asthma in Primary Care
- ClinicalTrials.gov ID
- NCT07609134
- Acronym / sponsor ID
- REC202602014
- Conditions
- Asthma, Self-management, Asthma Control
- Keywords
- Asthma, self-management education, asthma control, primary care, nursing
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 40 participants (estimated)
- Lead sponsor
- Royal College of Surgeons, IrelandUniversity, hospital or other
- Study start
- May 2026 (estimated)
- Primary completion
- Jan 2027 (estimated)
- Study completion
- Jan 2027 (estimated)
- First posted
- 27 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Asthma is a common medical condition in Ireland. Adult patients tend to have periods when their asthma is stable and periods when it worsens. In order to reduce these periods of worsening asthma, effective ongoing management is required day to day by adults with asthma. Teaching adults how to manage their asthma effectively, plays a huge role in improving their asthma and having a better overall quality of life. This education on managing asthma has many different parts to it. Most adults will discover they have asthma through their general practitioner (GP) and it will be continued to be checked and managed through their GP or general practice nurse (GPN) in their primary care clinic for the duration of their lives.
This research study is taking place to find out if a new education programme, will help adults manage their asthma better and improve the symptoms of asthma, reducing its overall impact on day-to-day life. This study is also looking at how easy it is to introduce and for nurses to deliver this study within a GP/ primary care centre. This study is to find out if this education programme works in a real life setting and if it can lead to better control of asthma for adults.
Study design
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| WASP intervetion | Experimental | Other: WASP asthma self-management programme |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Adults over 18 years old
- Adults who meet one of the following criteria:
- a physician's diagnosis of asthma; coded as asthma (R96) as per the international classification of primary care (ICPC) or international classification of diseases (ICD) code J45 with associated use of asthma medications for 6 months prior to study enrolment.
Key exclusion criteria (5 listed)
- Adults under 18 years old
- Adults with no diagnosis of asthma
- Adults receiving asthma education in a specialist hospital or community setting
- Adults unable to give informed consent
- Smoking ≥ 10 Pack Year History
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| WASP asthma self-management programmeall participants will received the WASP intervention which includes (asthma education, self-management training and behaviour change strategies) | Other | WASP intervetion |
Primary outcome
Feasibility of implementation
Time frame: 6 months
In terms of: recruitment, retention, response rates and service users' views of the intervention
Education
Time frame: 6 months
Establish the nurses' frequency of education implementation
6 secondary outcomes
Asthma Control Test Questionnaire
Time frame: 6 months
Modified asthma self-efficacy questionnaire
Time frame: 6 months
Mini Asthma Quality of Life Questionnaire (mAQLQ)
Time frame: 6 months
Spirometry - Forced expiratory volume in 1 second (FEV1)
Time frame: 6 months
Spirometry - Forced Vital Capacity (FVC)
Time frame: 6 months
Spirometry - Peak expiratory flow (PEF)
Time frame: 6 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 May 2026.
- Individual participant dataSharing planned: Undecided. The data that support the findings of this study will be available from the corresponding author upon reasonable request
Related trials for Asthma
RecruitingPhase 3
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
Severe Asthma
Active, not recruiting
Nasal Immune Challenge Study
Innate Inflammatory Response, Asthma
Not yet recruiting
Reducing Exposure With Air Cleaners and Technology
Asthma, COPD (Chronic Obstructive Pulmonary Disease)
Not yet recruiting
Bilevel Positive Airway Pressure (BPAP) for Severe Asthma
Pediatric Asthma, Acute Asthma
Recruiting
Lung Immune Challenge Study: Controlled Exposure to Inhaled Resiquimod (R848)
Innate Immunity, Mucosal Immunity
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing WASP asthma self-management programme in people with Asthma and Self-management, run by Royal College of Surgeons, Ireland at 1 site in Ireland.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 27 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Ireland. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Joanne Walsh, MSc (01-4022300, joannewalsh21@rcsi.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Feasibility of implementation (time frame: 6 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 May 2026.